ConductScience.org, home

Paper7698121

Chemotherapy of lepromatous leprosy: recent developments and prospects for the future.

Gelber RH. Eur J Clin Microbiol Infect Dis, 1994. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Chemotherapy of lepromatous leprosy: recent developments and prospects for the future. Papers, record 7698121. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7698121

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemotherapy of lepromatous leprosy: recent developments and prospects for the future.
PubMed
Journal
Eur J Clin Microbiol Infect Dis
PubMed
Year
1994
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.71
iCite
Revised in PubMed
2026-10-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gelber RHR H

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leprostatic AgentsMajor topic
Leprosy, LepromatousMajor topic
Animals
Drug Therapy, Combination
Forecasting
Humans
Mice
Mycobacterium leprae

Source PubMed

Download CSV of topics

References68

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18392100Sparfloxacin is more bactericidal than ofloxacin against Mycobacterium leprae in mice.Int J Lepr Other Mycobact Dis1993https://conductscience.org/library/papers/8392100PubMed
27031389A brief review of experiences with short-term clinical trials monitored by mouse-foot-pad-inoculation.Lepr Rev1981https://conductscience.org/library/papers/7031389PubMed
33549940Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse.Int J Lepr Other Mycobact Dis1987https://conductscience.org/library/papers/3549940PubMed
469411Results at 5 years of a controlled comparison of a 6-month and a standard 18-month regimen of chemotherapy for pulmonary tuberculosis.Am Rev Respir Dis1977https://conductscience.org/library/papers/69411PubMed
54562383Combinations of drugs against Mycobacterium leprae studied in mice.Int J Lepr Other Mycobact Dis1972https://conductscience.org/library/papers/4562383PubMed
6661479Drugs for combined therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general review.Lepr Rev1978https://conductscience.org/library/papers/661479PubMed
76806990Chemotherapy of leprosy for control programmes.World Health Organ Tech Rep Ser1982https://conductscience.org/library/papers/6806990PubMed
81648889Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1648889PubMed
93522770Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone.Int J Lepr Other Mycobact Dis1986https://conductscience.org/library/papers/3522770PubMed
108257487Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy.J Infect Dis1993https://conductscience.org/library/papers/8257487PubMed
112407654Effective vaccination of mice against leprosy bacilli with subunits of Mycobacterium leprae.Infect Immun1990https://conductscience.org/library/papers/2407654PubMed
123747702The rate of relapse in lepromatous leprosy following completion of twenty years of supervised sulphone therapy.Lepr Rev1986https://conductscience.org/library/papers/3747702PubMed
13795312Dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.Am J Trop Med Hyg1976https://conductscience.org/library/papers/795312PubMed
141563772Vaccination of mice with a soluble protein fraction of Mycobacterium leprae provides consistent and long-term protection against M. leprae infection.Infect Immun1992https://conductscience.org/library/papers/1563772PubMed
157002811Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.Int J Lepr Other Mycobact Dis1980https://conductscience.org/library/papers/7002811PubMed
1649662Sulphone resistance in leprosy. A review of one hundred proven clinical cases.Lancet1975https://conductscience.org/library/papers/49662PubMed
172256685Primary dapsone-resistant Hansen's disease in California. Experience with over 100 Mycobacterium leprae isolates.Arch Dermatol1990https://conductscience.org/library/papers/2256685PubMed
183325579Application of the thymectomized-irradiated mouse to the detection of persisting Mycobacterium leprae.Int J Lepr Other Mycobact Dis1987https://conductscience.org/library/papers/3325579PubMed
192198315Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.Int J Lepr Other Mycobact Dis1990https://conductscience.org/library/papers/2198315PubMed
204398128Kinetic testing of drugs against Mycobacterium leprae in mice. Activity of cephaloridine, rifampin, streptovaricin, vadrine, and viomycin.Am J Trop Med Hyg1971https://conductscience.org/library/papers/4398128PubMed

See all 68 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
41699691
Protocol of a comparative multicentric non inferiority clinical trial of WHO MBMDT with a new monthly chemotherapy regimen containing rifampicin, moxifloxacin and clarithromycin (RMC) on multibacillary patients from India.
Trials2026https://conductscience.org/library/papers/41699691PubMed
28850614Nitazoxanide is active against Mycobacterium leprae.PLoS One2017https://conductscience.org/library/papers/28850614PubMed
27175099Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy.Risk Manag Healthc Policy2016https://conductscience.org/library/papers/27175099PubMed
22048122Advances and hurdles on the way toward a leprosy vaccine.Hum Vaccin2011https://conductscience.org/library/papers/22048122PubMed
18573938Powerful bactericidal activity of moxifloxacin in human leprosy.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18573938PubMed
7698114Mycobacterial taxonomy.Eur J Clin Microbiol Infect Dis1994https://conductscience.org/library/papers/7698114PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7698121

GET https://conductscience.org/api/papers/v1/7698121/references?page=2